Trial Profile
A Randomized, Open-label, 4-way Crossover Single Dose Clinical Trial to Investigate the Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 When Administered Alone and in Combination in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Chlortalidone (Primary) ; Losartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 18 Mar 2015 New trial record